|
|
|
| Setting the Standard in Cell and Gene Therapy, Together | Sartorius shares your mission to develop life-changing cell and gene therapies. Accelerate commercialization with end-to-end solutions that deliver reproducibility, scalability, and the quality needed to simplify regulatory approvals. From discovery, to process development, to clinical and commercial manufacturing, our portfolio of proven solutions helps you achieve faster time-to-market while saving costs. Together, we're setting the standard in cell and gene therapy. Learn more here. |
|
|
|
|
By Tyler Menichiello, contributing editor | At the 2024 Bioprocessing Summit, a panel of CMC experts spoke about the challenges commercializing gene therapies, specifically focusing on considerations for late-stage process changes. |
|
|
|
Due to the bespoke nature of autologous CAR-T manufacturing, facilities can only produce so many therapies at once. Our panelists discuss these challenges and the need for innovative solutions. |
|
|
| Manifolding For Scale-Up, Safety, And Speed | Article | By Chris Hofmann and Ian Burdick, Charter Medical | The use of manifolds to fill bags for bioprocessing or advanced therapies contributes to time savings, improved process quality, and optimal use of cleanroom and personnel resources. |
|
|
| Selecting CGT Manufacturing Processes For Automation | Article | Invetech | Informing automation decisions involves pinpointing crucial processes for successful batch productions. Prioritize automating processes with the highest risk of human error and the greatest labor cost. |
|
|
|
|
| Overcoming Challenges In CGT Development | Webinar | CPC | Consider these connector solutions for sterility, chemical compatibility, and ultra-low temperature challenges when setting up a therapeutic process for long-term success. |
|
|
| Data-Driven CHO Bioprocess Optimization And Scale-Up | Application Note | 908 Devices | Learn how at-line cell culture media analysis enhances mAb production by refining nutrient feed strategies, reducing toxic metabolites, and improving yields while lowering costs. |
|
|
|
|
|
|
|
| It's no secret that on-going research aims to improve the efficacy and specificity of non-viral approaches for genetic engineering. But the field is rapidly evolving with research aimed at improving transfection efficiency, targeting, and safety profiles of non-viral delivery systems. Join Cell & Gene Live to discuss the most notable approaches and recent breakthroughs as well as promising non-viral vectors used in clinical trials. Attendance is free thanks to the support of MaxCyte. |
|
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
